Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
| Fund/benchmark | Change | |
|---|---|---|
| Price | Life Science REIT PLC (Ordinary Share) | +24.72% |
| NAV | Life Science REIT PLC (Ordinary Share) | -11.25% |
| Morningstar's Benchmark | No benchmark | -- |
Announcements
- Holding(s) in Company
- Form 8.3 - Life Science REIT plc
- Form 8.3 - LIFE SCIENCE REIT PLC
- Form 8.5 (EPT/RI) - Replacement of Life Science
- Form 8.3 Life Science REIT plc
- Form 8.3 - British Land Company plc, The
- Form 8.3 - Life Science REIT PLC
- Form 8.5 (EPT/RI) - Life Science REIT plc
- Form 8.3 Life Science REIT Plc
- Form 8.3 - British Land Company PLC
More ▼
Key statistics
On Friday, Life Science REIT PLC (LABS:LSE) closed at 42.50, -13.27% below its 52-week high of 49.00, set on Jun 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Shares outstanding | 350.00m |
|---|---|
| Market cap | 154.00m GBP |
| Total assets | 341.80m GBP |
| Total expense ratio | -- |
| High | 43.20 |
| Low | 42.50 |
| Previous close | 44.00 |
| Average volume | 25.03m |
|---|---|
| YTD Change | +7.87% |
| Beta | -0.1797 |
| Diluted NAV (est) | 66.60 |
| Diluted NAV (last pub) | 66.60 |
| Premium/Discount | -36.19% |
| Net Gearing | +44.61% |
| Annual div (ADY) | -- |
|---|---|
| Annual div yield (ADY) | -- |
| Div ex-date | Oct 03 2024 |
| Div pay-date | Oct 31 2024 |
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼
